| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -10% |
| 3Y CAGR | +11% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +41% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,273.90 +51.90 (2.34%) | 17,266.06 | 25.47 | 5.12 | ||
PfizerPFIZER | ₹3,687.20 +74.90 (2.07%) | 16,875.42 | 22.95 | 4.02 | ||
Natco PharmaNATCOPHARM | ₹790.20 -1.65 (0.21%) | 15,499.23 | 13.54 | 1.48 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,051.50 +63.00 (1.05%) | 15,186.88 | 89.53 | 17.4 |